Dabigatran etexilate Not Yet Recruiting Phase 3 Trials for Thromboembolism / Nonvalvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02313584Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk